Evening Standard

The Beckley Retreat - a trip of a lifetime?

Source: The Good Hope Estate in Jamaica

I’m sitting under tent canvas, eye-mask on, swaddled like a newborn in a linen blanket. There is a woman singing a Jamaican folk song somewhere in the distance and the air is perfumed with sage and incense. Time and space are abstract concepts and I’m overwhelmed by a deep feeling of surrender. I think I might be sobbing.

Welcome to Jamaica’s Good Hope Estate, a 200-acre former plantation which is now also the home to the Beckley Foundation’s psilocybin retreats. Contrary to what my editors think, I’m not here for a Caribbean jolly but rather to experience firsthand the work they are doing to discover the therapeutic benefits of magic mushrooms.

The Beckley Foundation has long been a pioneer in the field. When the rest of the world was experimenting recreationally and LSD in the Sixties, Beckley’s founder, eccentric aristocrat Amanda Fielding, recognised the powerful benefits of psychedelics for healing trauma, creative blocks and treating depression — a potent natural alternative to the sometimes-lazy prescription of SSRIs in modern medicine.

You’re reading a preview, subscribe to read more.

More from Evening Standard

Evening Standard4 min read
Gambling Row Deepens As Cabinet Minister Says He Placed Bets On Election Date
The Westminster gambling row has deepened after a Cabinet minister revealed he had placed bets on the date of the General Election. Scotland Secretary Alister Jack denied having broken any rules but said he put three wagers on the timing of the July
Evening Standard2 min read
Manchester United 'Close To £27m Erik Ten Hag Deal' As Manuel Ugarte Bid Tabled
Manchester United are reportedly on the verge of agreeing a new contract with manager Erik ten Hag as they also pursue a deal for Paris Saint-Germain midfielder Manuel Ugarte. Long-running questions over the Dutchman’s Old Trafford future were finall
Evening Standard2 min read
Haleon Sells Nicotine Replacement Therapy Business Outside Of US For £500m
Sensodyne and Panadol maker Haleon has agreed to sell its nicotine replacement brands outside of the US for £500 million, as part of ongoing efforts to trim down its consumer health portfolio. The healthcare giant said it was selling its nicotine rep

Related Books & Audiobooks